What's the (end) point?

Eur Respir J. 2015 Mar;45(3):854-5. doi: 10.1183/09031936.00214214.

Authors

Mark-Jan Ploegstra¹, Rolf M F Berger²

Affiliations

¹ Dept of Paediatric Cardiology, Center for Congenital Heart Diseases, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands M.Ploegstra@umcg.nl.
² Dept of Paediatric Cardiology, Center for Congenital Heart Diseases, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

PMID: 25726540
DOI: 10.1183/09031936.00214214

No abstract available

Publication types

Letter
Comment

MeSH terms

Endothelin Receptor Antagonists / therapeutic use*
Female
Humans
Hypertension, Pulmonary / therapy*
Lung Transplantation*
Male
Phosphodiesterase 5 Inhibitors / therapeutic use*
Prostaglandins I / therapeutic use*

Substances

Endothelin Receptor Antagonists
Phosphodiesterase 5 Inhibitors
Prostaglandins I